Gateway to Translation Webinar: Exhalation Technology
The “Gateway to Translation” (G2T) webinar series is a joint initiative between the University of Cambridge (Cambridge Academy of Therapeutic Sciences, CATS) and the University of Manchester (Translation Manchester).
The aim of these monthly webinars is to stimulate the translation of research into the clinics by educating academics about trends, technologies and research in the commercial sphere and by facilitating collaborations between academia and the medtech, biotech and pharma industry sectors. Recordings from previous webinars are available here.
Stig Lytke Brejl – CTO at Exhalation Technology Ltd
The October 2024 webinar of this series, hosted by The University of Manchester (Translation Manchester), was on Tuesday 29th October 2-3pm (via Zoom). Our guest speaker was Stig Lytke Brejl, CTO at Exhalation Technology Ltd.
Exhalation Technology aims to revolutionise respiratory care. Their platform technology, Inflammacheck®, offers a first of its kind, non-invasive, cost-effective breath test designed for Point of Care use. In parallel, Exhalation is investigating the potential of their technology in other conditions, including COPD, asthma, and pneumonia.
Topic: “Early Detection of Lung Cancer by Inflammatory Biomarkers in Breath; a Potential Paradigm Shift in Lung Cancer Screening”
Guest Speaker: Stig Lytke Brejl, CTO at Exhalation Technology
Date and Time: Wednesday 22nd May, 2-3pm
The webinar was chaired by Dr Sean Knight, Academic Clinical Lecturer and specialist registrar in Respiratory Medicine at the University of Manchester.
Click to learn more about the speaker
Stig holds an MSc in Mechanical Engineering as well as a business degree from the Copenhagen Business School. Stig has almost 35 years of professional experience, holding management positions in different companies. Prior to joining Exhalation Technology, Stig worked as an international Management Consultant serving multiple clients across various industries.
Stig has been with Exhalation Technology since 2012. His focus has been on strategy development and implementation, but during his years at Exhalation Technology he has also gained substantial insight in and practical experience with MedTech product development, quality assurance and regulatory approval. In parallel to his job at Exhalation Technology, Stig has assumed the role as Chairman of the Board at OSAA Innovation, a small Danish start-up developing a mobile solution for IV-therapy.
Watch a recording from the event below:
Contact Us
Email:
0 Comments